Diabetes mellitus and cardiogenic shock in acute myocardial infarction

European Journal of Heart Failure

Volumn 7, Issue 5, 2005, Pages 834-839

  Lindholm, M G ^a   Boesgaard, S ^b   Torp Pedersen, C ^b   Kober L ^b  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b NONE

Author keywords

Cardiogenic shock; Diabetes; Heart failure; MI

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INDEX; HEART LEFT VENTRICLE WALL MOTION; HEART REINFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

AGED; COMORBIDITY; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SHOCK, CARDIOGENIC;

EID: 23744451581     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.09.007     Document Type: Article

References (18)

1. D.R.J. Holmes, E.R. Bates, N.S. Kleiman, Z. Sadowski, J.H. Horgan, and D.C. Morris Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries J. Am. Coll. Cardiol. 26 3 1995 668 674
2. R.M. Califf, and J.R. Bengtson Cardiogenic shock N. Engl. J. Med. 330 24 1994 1724 1730
3. R.J. Goldberg, N.A. Samad, J. Yarzebski, J. Gurwitz, C. Bigelow, and J.M. Gore Temporal trends in cardiogenic shock complicating acute myocardial infarction N. Engl. J. Med. 340 15 1999 1162 1168
4. J.S. Hochman, L.A. Sleeper, J.G. Webb, T.A. Sanborn, H.D. White, and J.D. Talley Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries For Cardiogenic Shock N. Engl. J. Med. 341 9 1999 625 634
5. J.S. Hochman, L.A. Sleeper, H.D. White, V. Dzavik, S.C. Wong, and V. Menon One-year survival following early revascularization for cardiogenic shock JAMA 285 2 2001 190 192
6. T.J. Ryan, E.M. Antman, N.H. Brooks, R.M. Califf, L.D. Hillis, and L.F. Hiratzka 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Circulation 100 9 1999 1016 1030
7. M.G. Lindholm, J. Aldershvile, C. Sundgreen, E. Jørgensen, K. Saunamaki, and S. Boesgaard Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction Eur. J. Heart Fail. 2003
8. M.G. Lindholm, L. Kober, S. Boesgaard, C. Torp-Pedersen, and J. Aldershvile Cardiogenic shock complicating acute MI: significance of time to development of shock Eur. Heart J. 2003
9. I. Gustafsson, P. Hildebrandt, M. Seibaek, T. Melchior, C. Torp-Pedersen, and L. Kober Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen Eur. Heart J. 21 23 2000 1937 1943
10. T. Melchior, L. Kober, C.R. Madsen, M. Seibaek, G.V. Jensen, and P. Hildebrandt Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation Eur. Heart J. 20 13 1999 973 978
11. K.L. Lee, L.H. Woodlief, E.J. Topol, W.D. Weaver, A. Betriu, and J. Col Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators Circulation 91 6 1995 1659 1668
12. K.H. Mak, D.J. Moliterno, C.B. Granger, D.P. Miller, H.D. White, and R.G. Wilcox Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries J. Am. Coll. Cardiol. 30 1 1997 171 179
13. D.M. Shindler, S.T. Palmeri, T.A. Antonelli, L.A. Sleeper, J. Boland, and T.P. Cocke Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J. Am. Coll. Cardiol. 36 3 Suppl A 2000 1097 1103
14. The Trace Study Group The Trandolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population Am. J. Cardiol. 73 10 1994 44C 50C
15. K.L. Lee, L.H. Woodlief, E.J. Topol, W.D. Weaver, A. Betriu, and J. Col Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I investigators Circulation 91 6 1995 1659 1668
16. J.V. Tedesco, R.S. Wright, B.A. Williams, S.L. Kopecky, D.L. Dvorak, and G.S. Reeder Effect of diabetes on the mortality risk of cardiogenic shock in a community-based population Mayo Clin. Proc. 78 5 2003 561 566
17. J.S. Hochman, L.A. Sleeper, H.D. White, V. Dzavik, S.C. Wong, and V. Menon One-year survival following early revascularization for cardiogenic shock JAMA 285 2 2001 190 192
18. M. Roffi, D.J. Moliterno, B. Meier, E.R. Powers, C.L. Grines, and P.M. DiBattiste Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: do tirofiban and ReoPro give similar efficacy outcomes trial (TARGET) 1-year follow-up Circulation 105 23 2002 2730 2736